EP 3990922 A1 20220504 - DETECTION OF ANTI-TNF ALPHA DRUG BIOLOGICS AND ANTI-DRUG ANTIBODIES
Title (en)
DETECTION OF ANTI-TNF ALPHA DRUG BIOLOGICS AND ANTI-DRUG ANTIBODIES
Title (de)
NACHWEIS VON ANTI-TNF-ALPHA BIOLOGIKA UND ANTI-WIRKSTOFF-ANTIKÖRPERN
Title (fr)
DÉTECTION D'AGENTS BIOLOGIQUES MÉDICAMENTEUX ANTI-TNF ALPHA ET D'ANTICORPS ANTI-MÉDICAMENTS
Publication
Application
Priority
- US 201962866344 P 20190625
- US 2020032859 W 20200514
Abstract (en)
[origin: WO2020263450A1] The disclosure provides fluorescence resonance energy transfer (FRET) assays to detect the presence of anti-TNFα biologics and/or their autoantibodies in a patient sample to monitor TNFα inhibitor therapy and to guide treatment decisions.
IPC 8 full level
G01N 33/564 (2006.01); G01N 33/68 (2006.01)
CPC (source: EP)
G01N 33/564 (2013.01); G01N 33/6857 (2013.01); G01N 2333/525 (2013.01)
Citation (search report)
See references of WO 2020263450A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2020263450 A1 20201230; EP 3990922 A1 20220504; JP 2022540764 A 20220920
DOCDB simple family (application)
US 2020032859 W 20200514; EP 20730804 A 20200514; JP 2021576466 A 20200514